189 related articles for article (PubMed ID: 35902379)
1. CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer.
Aiyappa-Maudsley R; Storr SJ; Rakha EA; Green AR; Ellis IO; Martin SG
J Pathol Clin Res; 2022 Nov; 8(6):550-566. PubMed ID: 35902379
[TBL] [Abstract][Full Text] [Related]
2. Expression of CYP2S1 and CYP2W1 in breast cancer epithelial cells and modulation of their expression by synthetic methoxy stilbenes.
Szaefer H; Licznerska B; Cykowiak M; Baer-Dubowska W
Pharmacol Rep; 2019 Dec; 71(6):1001-1005. PubMed ID: 31561186
[TBL] [Abstract][Full Text] [Related]
3. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO
Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963
[TBL] [Abstract][Full Text] [Related]
4. Preparation and application of anti-peptide antibodies for detection of orphan cytochromes P450.
Hodek P; Hrdinova J; Macova I; Soucek P; Mrizova I; Burdova K; Kizek R; Hudecek J; Stiborova M
Neuro Endocrinol Lett; 2015; 36 Suppl 1():38-45. PubMed ID: 26757124
[TBL] [Abstract][Full Text] [Related]
5. The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer - a pilot study.
Edler D; Stenstedt K; Ohrling K; Hallström M; Karlgren M; Ingelman-Sundberg M; Ragnhammar P
Eur J Cancer; 2009 Mar; 45(4):705-12. PubMed ID: 19118998
[TBL] [Abstract][Full Text] [Related]
6. Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1.
Nishida CR; Lee M; de Montellano PR
Mol Pharmacol; 2010 Sep; 78(3):497-502. PubMed ID: 20566689
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma.
Zhang K; Jiang L; He R; Li BL; Jia Z; Huang RH; Mu Y
Tumour Biol; 2014 Aug; 35(8):7669-73. PubMed ID: 24801906
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia as a modulator of cytochromes P450: Overexpression of the cytochromes CYP2S1 and CYP24A1 in human liver cancer cells in hypoxia.
Cabrera-Cano A; Dávila-Borja VM; Juárez-Méndez S; Marcial-Quino J; Gómez-Manzo S; Castillo-Rodríguez RA
Cell Biochem Funct; 2021 Jun; 39(4):478-487. PubMed ID: 33377261
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer-specific cytochrome P450 2W1: intracellular localization, glycosylation, and catalytic activity.
Gomez A; Nekvindova J; Travica S; Lee MY; Johansson I; Edler D; Mkrtchian S; Ingelman-Sundberg M
Mol Pharmacol; 2010 Dec; 78(6):1004-11. PubMed ID: 20805301
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers.
Chung FF; Mai CW; Ng PY; Leong CO
Curr Cancer Drug Targets; 2016; 16(1):71-8. PubMed ID: 26563883
[TBL] [Abstract][Full Text] [Related]
11. RNA expression of cytochrome P450 in Mexican women with breast cancer.
Bandala C; Floriano-Sánchez E; Cárdenas-Rodríguez N; López-Cruz J; Lara-Padilla E
Asian Pac J Cancer Prev; 2012; 13(6):2647-53. PubMed ID: 22938436
[TBL] [Abstract][Full Text] [Related]
12. CYP2W1, CYP4F11 and CYP8A1 polymorphisms and interaction of CYP2W1 genotypes with risk factors in Mexican women with breast cancer.
Cárdenas-Rodríguez N; Lara-Padilla E; Bandala C; López-Cruz J; Uscanga-Carmona C; Lucio-Monter PF; Floriano-Sánchez E
Asian Pac J Cancer Prev; 2012; 13(3):837-46. PubMed ID: 22631658
[TBL] [Abstract][Full Text] [Related]
13. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
[TBL] [Abstract][Full Text] [Related]
14. The expression of CYP2W1: a prognostic marker in colon cancer.
Stenstedt K; Hallstrom M; Johansson I; Ingelman-Sundberg M; Ragnhammar P; Edler D
Anticancer Res; 2012 Sep; 32(9):3869-74. PubMed ID: 22993331
[TBL] [Abstract][Full Text] [Related]
15. A Review on the Expression and Metabolic Features of Orphan Human Cytochrome P450 2S1 (CYP2S1).
Yan P; Eng OC; Yu CJ
Curr Drug Metab; 2018; 19(11):917-929. PubMed ID: 29804525
[TBL] [Abstract][Full Text] [Related]
16. A transcriptomic approach to elucidate the physiological significance of human cytochrome P450 2S1 in bronchial epithelial cells.
Madanayake TW; Lindquist IE; Devitt NP; Mudge J; Rowland AM
BMC Genomics; 2013 Nov; 14():833. PubMed ID: 24279958
[TBL] [Abstract][Full Text] [Related]
17. Retrospective assessment of cyclin-dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancer.
Saidy B; Rakha EA; Green AR; Ellis IO; Martin SG; Storr SJ
J Cell Mol Med; 2020 Jun; 24(11):6263-6271. PubMed ID: 32352232
[TBL] [Abstract][Full Text] [Related]
18. Characterization and expression of extrahepatic CYP2S1.
Deb S; Bandiera SM
Expert Opin Drug Metab Toxicol; 2009 Apr; 5(4):367-80. PubMed ID: 19368491
[TBL] [Abstract][Full Text] [Related]
19. KRT13, FAIM2 and CYP2W1 mRNA expression in oral squamous cell carcinoma patients with risk habits.
Hartanto FK; Karen-Ng LP; Vincent-Chong VK; Ismail SM; Mustafa WM; Abraham MT; Tay KK; Zain RB
Asian Pac J Cancer Prev; 2015; 16(3):953-8. PubMed ID: 25735388
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.
Callagy GM; Pharoah PD; Pinder SE; Hsu FD; Nielsen TO; Ragaz J; Ellis IO; Huntsman D; Caldas C
Clin Cancer Res; 2006 Apr; 12(8):2468-75. PubMed ID: 16638854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
